ArticleCell death & disease2026

mTOR inhibition enhances the antitumor efficacy of pan-RAF-MEK blockade by inhibiting the ATF4-MTHFD2 pathway.

Feiyang Cai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.